Published in Korean J Pediatr on March 20, 2015
Dissecting Kawasaki disease: a state-of-the-art review. Eur J Pediatr (2017) 0.92
Use of corticosteroids during acute phase of Kawasaki disease. World J Clin Pediatr (2015) 0.77
The Clinical Profile of Kawasaki Disease in Algerian Children: A Single Institution Experience. J Trop Pediatr (2015) 0.75
Quercetin Inhibits Inflammasome Activation by Interfering with ASC Oligomerization and Prevents Interleukin-1 Mediated Mouse Vasculitis. Sci Rep (2017) 0.75
Pathogenetic determinants in Kawasaki disease: the haematological point of view. J Cell Mol Med (2017) 0.75
Sequencing technologies - the next generation. Nat Rev Genet (2009) 40.57
Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat Immunol (2007) 6.22
TGF-beta signaling in vascular fibrosis. Cardiovasc Res (2007) 2.86
ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet (2007) 2.77
Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediatr (2006) 2.63
Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation (2006) 2.56
Epidemiologic features of Kawasaki disease in Japan: results of the 2009-2010 nationwide survey. J Epidemiol (2012) 2.15
Epidemiologic features of Kawasaki disease in Japan: results of the 2007-2008 nationwide survey. J Epidemiol (2010) 2.09
Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease. Nat Genet (2011) 1.97
Next-generation sequencing: ready for the clinics? Clin Genet (2012) 1.75
Prevalence of coronary artery abnormality in incomplete Kawasaki disease. Pediatr Int (2007) 1.72
Epidemiology of Kawasaki disease in Asia, Europe, and the United States. J Epidemiol (2012) 1.70
Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment. Eur J Pediatr (2006) 1.61
A genome-wide association study identifies three new risk loci for Kawasaki disease. Nat Genet (2012) 1.58
Prediction of non-responsiveness to intravenous high-dose gamma-globulin therapy in patients with Kawasaki disease at onset. J Pediatr (2000) 1.58
Coronary artery lesions of incomplete Kawasaki disease: a nationwide survey in Japan. Eur J Pediatr (2011) 1.52
Transforming growth factor-beta signaling pathway in patients with Kawasaki disease. Circ Cardiovasc Genet (2010) 1.45
Complete and incomplete Kawasaki disease: two sides of the same coin. Eur J Pediatr (2011) 1.36
Transforming growth factor-beta1 mechanisms in aortic valve calcification: increased alkaline phosphatase and related events. Ann Thorac Surg (2007) 1.36
Epidemiologic features of Kawasaki disease in South Korea: data from nationwide survey, 2009-2011. Pediatr Infect Dis J (2014) 1.30
Two new susceptibility loci for Kawasaki disease identified through genome-wide association analysis. Nat Genet (2012) 1.30
ITPKC single nucleotide polymorphism associated with the Kawasaki disease in a Taiwanese population. PLoS One (2011) 1.21
Common variants in CASP3 confer susceptibility to Kawasaki disease. Hum Mol Genet (2010) 1.20
Commentary: translation of Dr. Tomisaku Kawasaki's original report of fifty patients in 1967. Pediatr Infect Dis J (2002) 1.20
CASP3 gene single-nucleotide polymorphism (rs72689236) and Kawasaki disease in Taiwanese children. J Hum Genet (2010) 1.19
ITPKC and CASP3 polymorphisms and risks for IVIG unresponsiveness and coronary artery lesion formation in Kawasaki disease. Pharmacogenomics J (2011) 1.17
Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan. Pediatr Infect Dis J (2008) 1.09
Replication and meta-analysis of GWAS identified susceptibility loci in Kawasaki disease confirm the importance of B lymphoid tyrosine kinase (BLK) in disease susceptibility. PLoS One (2013) 0.99
The T helper type 17/regulatory T cell imbalance in patients with acute Kawasaki disease. Clin Exp Immunol (2010) 0.99
Identification of KCNN2 as a susceptibility locus for coronary artery aneurysms in Kawasaki disease using genome-wide association analysis. J Hum Genet (2013) 0.91
Intrinsic cancer subtypes--next steps into personalized medicine. Cell Oncol (Dordr) (2015) 0.90
Understanding the pathogenesis of Kawasaki disease by network and pathway analysis. Comput Math Methods Med (2013) 0.84
New era for personalized medicine: the diagnosis and management of age-related macular degeneration. Clin Experiment Ophthalmol (2009) 0.83
Parents with a history of Kawasaki disease whose child also had the same disease. Pediatr Int (2011) 0.83
A replication study for association of ITPKC and CASP3 two-locus analysis in IVIG unresponsiveness and coronary artery lesion in Kawasaki disease. PLoS One (2013) 0.83
Personalized medicine strategies for managing patients with parkinsonism and cognitive deficits. Metabolism (2012) 0.81
Transforming growth factor beta receptor II polymorphisms are associated with Kawasaki disease. Korean J Pediatr (2012) 0.81
Genetic polymorphism of SMAD5 is associated with Kawasaki disease. Pediatr Cardiol (2013) 0.78
Is personalized medicine a dream or a reality? Crit Rev Clin Lab Sci (2014) 0.78
Does hypertension begin in adolescence? Korean J Pediatr (2013) 0.77
Consortium-Based Genetic Studies of Kawasaki Disease in Korea: Korean Kawasaki Disease Genetics Consortium. Korean Circ J (2015) 0.77
Analysis of clinical characteristics and causes of chest pain in children and adolescents. Korean J Pediatr (2015) 0.75
Multicenter, Single-Arm, Phase IV Study of Combined Aspirin and High-Dose "IVIG-SN" Therapy for Pediatric Patients with Kawasaki Disease. Korean Circ J (2017) 0.75
Comparison of growth and pubertal progression in wild type female rats with different bedding types. Ann Pediatr Endocrinol Metab (2015) 0.75
A genome-wide association analysis identifies NMNAT2 and HCP5 as susceptibility loci for Kawasaki disease. J Hum Genet (2017) 0.75
Male-specific association of the FCGR2A His167Arg polymorphism with Kawasaki disease. PLoS One (2017) 0.75